Blog / Archives
BIO 2014 Update #1 Personalized Medicine-Megatrend Momentum Continues
Challenges Ahead But Sequencing Is A Driver We first reported on Personalized Medicine in 2010 with an article on the importance of Biomarkers for exploiting breakthroughs in the molecular basis...
Vertex (VRTX) Soars 42% On Cystic Fibrosis Breakthrough Update-1
Data To Be Submitted in Q4 For Approval Two Phase III studies with combination drug showed clinically significant improvements in lung function Rayno Life Science Pick and Deja Vu Trade Last April...
BIO International Convention San Diego, CA This Week
Biotech Stocks Weak After 30 Day Rally NASDAQ at 4365 We will be attending the 2014 BIO International Convention this week. We do not expect any major scientific developments but will try to keep...
Market Perks Up on FED Testimony-Rates To Stay Low… Update 1 6/19
Update June 19.. 3:10 p EDT Ten Yr 2.62%, U.S.equities flat,biotech mixed, jobless claims down. Japanese and European equities up. Iraq on front page. GOLD Up $41 Breaks Through Resistance at $1300...
Biotech Recap On a Down Day
NASDAQ Off 0.8% On Disappointing Economic Data and Spiking Crude Islamic militants took major cities in Iraq causing a spike in oil to $106. The energy sector rallied 0.7% with many smaller...
Biotech Stocks Get A Turbo Boost From Idenix Deal
Rally Retraces Correction Up To Mid-Point YTD Up until this week we have focused on large cap biopharmaceuticals because of revenue momentum, fair valuations and earnings. A risk -off sentiment due...
Look For Biotech Rally Today Sparked By Merck $3.9B Acquisition of Idenix… Update-1
Update-1.... 45 Minutes Before the Close 6/9...Risk On Biotech stocks soared today right at the open after news of $3.9B Idenix deal news was out. The XBI was up 5.4% on good volume. The XBI is more...
ASCO Oncology Stocks: Recap and Scoreboard- AGIO, MDVN, SGEN Winners
High Profile Biotechnology Companies with ASCO Presence Investors and traders waited toward the end of the ASCO Annual Meeting week to buy their favorite stocks. The biotech sector overall was...
Clinical Tools and Diagnostic Companies:Financial Metrics 2014 Q1Results
Clinical Diagnostic Stocks Were Hit By Bio-Bubble or Revenue Miss Potential upside in EXAS, NSTG and NEOG all are Rayno Dx and Tools picks. With "momentum trading" days over for now, revenue growth...
ASCO Update #4- No Boost For Oncology Stocks… Update-6/4 MDVN, PCYC, SGEN
Update 6/4 Snap- back rally and big green screen! Update 6/3..... Daily Performance-from list below 9 winners, 12 losers Rayno Biopharmaceutical Picks in bold--- Winners: AGIO, INCY, SGEN, EPZM,...